Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · IEX Real-Time Price · USD
3.090
+0.100 (3.34%)
May 3, 2024, 10:34 AM EDT - Market open

Conduit Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021
Market Capitalization
221336177-
Market Cap Growth
-89.60%--
Enterprise Value
2183331831
PE Ratio
-627.90-627.90-36.25-
PB Ratio
-735.06-735.06-17.56-
P/FCF Ratio
-43.49-43.49-78.19-
P/OCF Ratio
-43.49-43.49-78.19-
EV/EBITDA Ratio
-1026.79-1026.79-37.50-0.20
EV/EBIT Ratio
-1026.79-1026.79-37.50-0.20
EV/FCF Ratio
-43.07-43.07-80.88-0.35
Debt / Equity Ratio
-2.16-2.16-0.60-0.13
Debt / EBITDA Ratio
-3.04-3.04-1.25-0.20
Debt / FCF Ratio
-0.13-0.13-2.69-0.35
Quick Ratio
2.352.3500
Current Ratio
3.183.1800.05
Interest Coverage
-1.54-1.54--
Return on Equity (ROE)
7.30%7.30%97.00%-
Return on Assets (ROA)
-11.10%-11.10%-4.80%-
Return on Capital (ROIC)
-996.59%-996.59%79.08%61.10%
Earnings Yield
-0.24%-0.16%-2.76%-
FCF Yield
-3.50%-2.30%-1.28%-
Buyback Yield / Dilution
-81.30%-81.30%96.26%-
Total Shareholder Return
-81.30%-81.30%96.26%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).